Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Thomas Bachmann, Joseph Eggler, and More


Bruker has appointed Thomas Bachmann to be president of its Bruker BioSpin Group. He will be responsible for two divisions: the Magnetic Resonance Spectroscopy division, which includes NMR, electron paramagnetic resonance, and compact magnetic resonance, and the Preclinical Imaging division, which includes MRI, magnetic particle imaging, X-ray micro-CT, and optical and PET/SPECT/CT molecular imaging.

Bachmann was CEO of Tecan for seven years, and for two years before that he was CEO of the Arbonia-Forster Group’s Steel Systems business.

Provista Diagnostics said this week that Joseph Eggler has joined the company as chief commercial officer. In the job, he will execute and manage the company’s sales efforts, as well as commercial aspects of the business.

Eggler previously was at Prometheus Laboratories, where he spent 12 years, and he has over two decades of experience in planning, sales and marketing development, and in identifying and creating key relationships, Provista said.

Peter Hirth has joined KineMed's board of directors. Hirth was previously CEO of Plexxikon. Before that he was president of Sugen and vice president of research at Boehringer Mannheim.

Applied Proteomics has appointed Genting Berhad Chairman and CEO Tan Sri Lim Kok Thay to its board of directors upon completion of a Series C funding round led by Genting Berhad (see story this issue).

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.